Since cell survival relies on the concerted adjustment of various signals, autophagic flux induced degradation of cyclin D1 may be one of the “passenger phenomena”, but not the major mechanism accounting for viability maintenance by combination treatment of lonafarnib and sorafenib in HCC cells. Here, CCND1 is linked to hepatocellular carcinoma.